BioCardia
BCDA
BCDA
24 hedge funds and large institutions have $5.49M invested in BioCardia in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
55% less call options, than puts
Call options by funds: $87K | Put options by funds: $195K
Holders
24
Holding in Top 10
–
Calls
$87K
Puts
$195K
Top Buyers
| 1 | +$494K | |
| 2 | +$57K | |
| 3 | +$28K | |
| 4 |
LPL Financial
San Diego,
California
|
+$23K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.2K |
Top Sellers
| 1 | -$832K | |
| 2 | -$276K | |
| 3 | -$109K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$41K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$17.1K |